Literature DB >> 1655614

Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.

S M Chittal1, P Brousset, J J Voigt, G Delsol.   

Abstract

Unusual clinicopathological features drew our attention to nine of 208 cases diagnosed as Hodgkin's disease. Lymph node biopsy specimens in these cases were immunostained with monoclonal antibodies against B-cell, T-cell and Reed-Sternberg cell associated antigens and epithelial membrane antigen (EMA). Reed-Sternberg-like and other atypical large cells were dispersed in a diffuse, small lymphocyte-rich background, consistent more often with the initial diagnosis of diffuse, lymphocyte predominance Hodgkin's disease. The clinical stage in these cases was unusually advanced (stages III and IV). Splenomegaly was a common feature (six of nine cases), the male to female ratio was 7:2 and the median age was 55 years (range 25-77). Response to recognized regimes for Hodgkin's disease treatment was poor in most cases, and three patients died early of their disease. Large cells were B-lymphocytes expressing EMA--an immunophenotype similar to nodular, lymphocyte predominance Hodgkin's disease. Reed-Sternberg cell and T-cell associated antigens were absent on large cells. Mature T-cells, with nuclear irregularities in some instances, predominated in the background. A more appropriate diagnostic category is, therefore, T-cell-rich B-cell lymphoma. The cases represent a 4-5% erroneous diagnosis of Hodgkin's disease and further suggest that there is a need for revision of criteria for the diagnosis of the diffuse, lymphocyte predominance variant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655614     DOI: 10.1111/j.1365-2559.1991.tb00024.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  T-cell/histiocyte-rich large B-cell lymphoma.

Authors:  Stefania Pittaluga; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

2.  Morphological variability of tumour cells in T-cell-rich B-cell lymphoma. A histopathological study of 14 cases.

Authors:  S Camilleri-Bröet; T Molina; J Audouin; A L Tourneau; J Diebold
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

3.  Orbital immunocytoma simulating Hodgkin's disease by mimicking Hodgkin- and Reed-Sternberg-like cells.

Authors:  W Radner; P Pfoser; W Sega; W Steinmair
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

Review 4.  T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification.

Authors:  Thomas Tousseyn; Christiane De Wolf-Peeters
Journal:  Virchows Arch       Date:  2011-11-12       Impact factor: 4.064

5.  Primary T-cell rich B-cell lymphoma of the common bile duct.

Authors:  J P Brouland; J Molimard; J Nemeth; P Valleur; A Galian
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Nodular lymphocyte-predominant hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas.

Authors:  Frank X Zhao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.

Authors:  R E Felgar; K R Steward; J B Cousar; W R Macon
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Pathological findings in human autoimmune lymphoproliferative syndrome.

Authors:  M S Lim; S E Straus; J K Dale; T A Fleisher; M Stetler-Stevenson; W Strober; M C Sneller; J M Puck; M J Lenardo; K S Elenitoba-Johnson; A Y Lin; M Raffeld; E S Jaffe
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.

Authors:  Peter Van Loo; Thomas Tousseyn; Vera Vanhentenrijk; Daan Dierickx; Agnieszka Malecka; Isabelle Vanden Bempt; Gregor Verhoef; Jan Delabie; Peter Marynen; Patrick Matthys; Chris De Wolf-Peeters
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941

Review 10.  [Lymphomas and lymphatic leukemias in the bone marrow].

Authors:  P Adam; L Quintanilla-Fend; F Fend
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.